FDA releases Clolar data

There were no surprises in data released by FDA and Ilex about ILXO's Clolar clofarabine in advance of Wednesday's Oncologic Drugs Advisory Committee meeting. ODAC's discussion of Clolar is

Read the full 292 word article

User Sign In